Research Reports Library
Here you will find copies of HDSA Research Reports that have been featured on the HDSA website and in our print publications. To read or download a report just click on the title.
2010 reports
Phase II Dimebon results are reported in an academic journal
More on Extrasynaptic Activity and Memantine in the HD Mice
A Sirtuin Inhibitor Enters Phase I Clinical Trials in Europe
A Molecular Switch: Studies of Phosphorylation
2009 reports
The 2009 Huntington's Disease Clinical Research Symposium
Synaptic Activity, Extrasynaptic Activity, and Memantine
The Search for Genetic Modifiers
Track-HD reports baseline findings
Strattera found ineffective in treating cognition in HD patients
Interview with Jan Nolta on stem cells
Mesenchymal stem cells in an animal model
FDA grants Dimebon orphan drug status
Cogane, a new BDNF inducer, enters the drug pipeline for HD
A breakthrough in generating stem cells from adult cells
Axonal transport is impaired in HD
Medivation to begin a Phase III trial of Dimebon
A new caspase six inhibitor is developed
Indiana researchers get NIH funding for HD research
Minocycline Phase II trial results disappointing
Acetylation of the HD protein - a new therapeutic target
An ampakine upregulates BNDF and improves memory
Stem cell research proceeds with hope and caution
Obama signs order lifting the ban on embryonic stem cell research
The ACR16 trial is enrolling participants
PGC-1 alpha gene modifies age of onset in HD
2008 reports
Weight loss in Huntington's Disease
Ethyl EPA (Miraxion) still in the pipeline
Huntington Study Group symposium 2008
ACR16 and cysteamine make progress in the pipeline
Nrf2 responsive genes are activated in HD
Ethyl-EPA reduces the rate of brain atrophy
An HDAC inhibitor ameliorates pathology in the R6/2 mice
Inhibitors of cytochrome c have therapeutic potential
CEP-1347 is added to the research pipeline
The Hereditary Disease Foundation Conference 2008
A New Stem Cell Line for HD: Another Model of the Disease
Immune System Over-Activated in HD
The FDA Approves a Phase IIb Clinical Trial of ACR16
Dimebon found safe and well tolerated in a Phase II trial
Sertaline helps two mouse models of HD
Raptor Pharmaceuticals Plan Phase II trial of Cysteamine
ALS clinical trial finds that minocycline accelerates disease progression
The Inaugural HSG Clinical Research Symposium
DIMOND (Dimebon Phase 2 Clinical Research Study) is Recruiting
first large transgenic animal model for Huntington's disease
Huntington Study Group Meetings Starting the Old and Planning for the New
Enrollment for DIMOND was completed in March 2008. Dimebon clinical trial is recruiting.
2008 CHDI HD Therapeutics Conference - A Report from an HD Family Perspective
Drugs which induce autophagy are added to the research pipeline
Early Neurotransmitter Problems in HD
Physical activity delays onset of motor symptoms in the R6/1 mouse model of HD
ALS clinical trial finds that minocycline accelerates disease progression
Yerkes researchers develop first transgenic nonhuman primate model of Huntington's disease
2007 Essays
The Huntington’s Disease Community’s Strategic Plan for the Cure
The Huntington’s Disease Community’s Strategic Plan for the Cure
The Huntington’s Disease Community’s Strategic Plan for the Cure